Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

Phase I Study of Decitabine and Rapamycin in Relapsed/Refractory Acute Myelogenous Leukemia

Jane L. Liesveld, MD, Kristen O'Dwyer, MD, Michael W. Becker, MD, Deborah Mulford, MD, Alison Walker, MD, Rui Chen, PhD, Jeremy Bechelli, MS, Karen Rosell, BS, Craig T. Jordan, PhD, Mohammad Minhajuddin, PhD, Gordon L. Phillips, II, MD

Blood (2012) 120 (21): 3549.

https://doi.org/10.1182/blood.V120.21.3549.3549

Published: 2012

Journal Articles

Randomized Comparison of Melphalan 200 Mg/m 2 v. 280 Mg/m 2 As a Preparative Regimen for Patients with Multiple Myeloma Undergoing Autologous Stem Cell Transplantation

William I. Bensinger, MD, Pamela S Becker, MD, PhD, Ted A. Gooley, PhD, Thomas Chauncey, MD, PhD, David G. Maloney, MD, PhD, Robert Vescio, MD, Ajay K. Gopal, MD, Damian J. Green, MD, Oliver W. Press, MD, PhD, Michael Lill, M.D., Leona Holmberg, MD, PhD, Jainulabdeen J Ifthikharuddin, MD, Gordon L. Phillips, II, MD

Blood (2012) 120 (21): 2009.

https://doi.org/10.1182/blood.V120.21.2009.2009

Published: 2012

Journal Articles

Phase I Study of Eltrombopag for Promoting Thrombopoiesis in Patients Undergoing Stem Cell Transplantation After Total Body Irradiation

Jane L. Liesveld, MD, Gordon L. Phillips, II, MD, Michael W. Becker, MD, Louis Constine, MD, Jonathan W. Friedberg, MD, Jeffrey Andolina, MD, MS, Laurie Milner, MD, Therese Smudzin, Ollivier Hyrien, PhD, Katie L Dawson, MD, MPH, Yuhchyau Chen, MD, PhD

Blood (2012) 120 (21): 219.

https://doi.org/10.1182/blood.V120.21.219.219

Published: 2012

Journal Articles

Phase I Study of Eltrombopag for Promoting Thrombopoiesis in Patients Undergoing Stem Cell Transplantation After Total Body Irradiation,

Jane L. Liesveld, MD, Gordon L. Phillips, II, MD, Michael W. Becker, MD, Louis Constine, MD, Jonathan Friedberg, MD, Jeffrey Andolina, MD, MS, Laurie Milner, MD, Jessica DeBolt, Ollivier Hyrien, PhD, Katie L Dawson, MD, MPH, Yuhchyau Chen, MD, PhD

Blood (2011) 118 (21): 3295.

https://doi.org/10.1182/blood.V118.21.3295.3295

Published: 2011

Journal Articles

High-Dose Therapy and Autologous Stem Cell Transplant (HD-ASCT) for Transformed Non-Hodgkin Lymphoma (NHL) In the Rituximab Era

Makiko Ban-Hoefen, MD, Jonathan W. Friedberg, MD, Jennifer L. Kelly, PhD, MPH, Steven H. Bernstein, MD, Jane L. Liesveld, MD, Faith Young, MD, Richard I Fisher, MD, Louis Constine, MD, Michael Becker, MD, Gordon L. Phillips, II, MD

Blood (2010) 116 (21): 2393.

https://doi.org/10.1182/blood.V116.21.2393.2393

Published: 2010

Journal Articles

Impact of Clinical Factors on Platelet Engraftments In Contemporary Stem Cell Transplantation.

Jane L. Liesveld, MD, Rui Chen, Joseph Pawlowski, Jessica Debolt, Michael Becker, Louis Constine, Gordon L. Phillips, II, MD, Ollivier Hyrien, Yuhchyau Chen

Blood (2010) 116 (21): 4522.

https://doi.org/10.1182/blood.V116.21.4522.4522

Published: 2010

Journal Articles

Blood CD34 Levels as a Predictor of Successful Peripheral Blood Stem Cell Mobilization In Consecutive Autologous Stem Cell Apheresis Patients From a Single Transplant Center

Sujatha Mogili, Rui Chen, Michael Becker, Faith Young, Gordon L. Phillips, II, MD, Sue Frauenhofer, Donna Cimbalo, Sean Czaja, Diane Nichols, Jane L. Liesveld, MD

Blood (2010) 116 (21): 4440.

https://doi.org/10.1182/blood.V116.21.4440.4440

Published: 2010

Journal Articles

The Hematopoietic Cell Transplantation-Specific Comorbidity Index (HCT-CI) and Survival After Extracorporeal Photopheresis, Pentostatin, and Reduced Dose Total Body Irradiation (TUFTs) Conditioning Prior to Allogeneic Stem Cell Transplantation (SCT)

Shahrukh Hashmi, MD, MPH, Jamie L Oliva, MS, NP, Jane L. Liesveld, MD, Gordon L. Phillips, II, MD, Diane Nichols, Michael Becker, MD

Blood (2010) 116 (21): 1337.

https://doi.org/10.1182/blood.V116.21.1337.1337

Published: 2010

Journal Articles

Salvage Autologous Hematpoeitic Stem Cell Transplants (AHSCT2) for Myeloma: Single Center Experience.

Bishoy Faltas, MD, Jane L. Liesveld, MD, Michael Becker, Jainulabdeen J. Ifthikharuddin, MD, Gordon L. Phillips, II, MD

Blood (2010) 116 (21): 4591.

https://doi.org/10.1182/blood.V116.21.4591.4591

Published: 2010

Journal Articles

A Phase I study using Bortezomib with Weekly Idarubicin for the Treatment of Elderly (>60 YEARS) and Relapsed Patients with Acute Myeloid Leukemia (AML)

Dianna Howard, MD, Jane Liesveld, MD, Gordon L. Phillips, II, MD, Monica L. Guzman, PhD, Craig T. Jordan, PhD

Blood (2008) 112 (11): 2953.

https://doi.org/10.1182/blood.V112.11.2953.2953

Published: 2008

Journal Articles

The CXCR4 Antagonist, AMD3100, Inhibits AML Transmigratory Activity but Does Not Alter Blast Proliferation or Survival.

Jane L. Liesveld, MD, Jeffrey E. Lancet, MD, Karen E. Rosell, BS, Jeremy Bechelli, BS, Camille N. Abboud, MD, Gordon L. Phillips, II, MD

Blood (2004) 104 (11): 2881.

https://doi.org/10.1182/blood.V104.11.2881.2881

Published: 2004

NARROW

Phase I Study of Decitabine and Rapamycin in Relapsed/Refractory Acute Myelogenous Leukemia

Randomized Comparison of Melphalan 200 Mg/m 2 v. 280 Mg/m 2 As a Preparative Regimen for Patients with Multiple Myeloma Undergoing Autologous Stem Cell Transplantation

Phase I Study of Eltrombopag for Promoting Thrombopoiesis in Patients Undergoing Stem Cell Transplantation After Total Body Irradiation

Phase I Study of Eltrombopag for Promoting Thrombopoiesis in Patients Undergoing Stem Cell Transplantation After Total Body Irradiation,

High-Dose Therapy and Autologous Stem Cell Transplant (HD-ASCT) for Transformed Non-Hodgkin Lymphoma (NHL) In the Rituximab Era

Impact of Clinical Factors on Platelet Engraftments In Contemporary Stem Cell Transplantation.

Blood CD34 Levels as a Predictor of Successful Peripheral Blood Stem Cell Mobilization In Consecutive Autologous Stem Cell Apheresis Patients From a Single Transplant Center

The Hematopoietic Cell Transplantation-Specific Comorbidity Index (HCT-CI) and Survival After Extracorporeal Photopheresis, Pentostatin, and Reduced Dose Total Body Irradiation (TUFTs) Conditioning Prior to Allogeneic Stem Cell Transplantation (SCT)

Salvage Autologous Hematpoeitic Stem Cell Transplants (AHSCT2) for Myeloma: Single Center Experience.

A Phase I study using Bortezomib with Weekly Idarubicin for the Treatment of Elderly (>60 YEARS) and Relapsed Patients with Acute Myeloid Leukemia (AML)

The CXCR4 Antagonist, AMD3100, Inhibits AML Transmigratory Activity but Does Not Alter Blast Proliferation or Survival.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only